HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 43797,
"next": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=38680&ordering=-name",
"previous": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=38640&ordering=-name",
"results": [
{
"accession": "CLO:0002638",
"name": "CTV-1 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002637",
"name": "CTPS cell",
"definition": "['disease: papilloma']",
"term_type": "cell line"
},
{
"accession": "CLO:0002635",
"name": "CTLL cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002636",
"name": "CTLL-2 cell",
"definition": "['disease: cytotoxic']",
"term_type": "cell line"
},
{
"accession": "CLO:0002634",
"name": "CTLA4 Ig-24 cell",
"definition": "['disease: expresses CTLA4Ig fusion protein']",
"term_type": "cell line"
},
{
"accession": "CLO:0002633",
"name": "CT96 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002632",
"name": "CT6-1D7 cell",
"definition": "['disease: hybridoma']",
"term_type": "cell line"
},
{
"accession": "CLO:0002631",
"name": "CT26.WT cell",
"definition": "['disease: carcinoma; model for testing immunotherapy protocols in vivo']",
"term_type": "cell line"
},
{
"accession": "CLO:0002630",
"name": "CT26.CL25 cell",
"definition": "['disease: carcinoma; model for testing immunotherapy protocols in vivo']",
"term_type": "cell line"
},
{
"accession": "CLO:0002072",
"name": "C subscript(6) cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002071",
"name": "C subscript(2) C subscript(12) cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002629",
"name": "CSMaß6C cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002628",
"name": "CSMaß1H cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "PR:000001810",
"name": "CSF-1/PDGF receptor-type tyrosine-protein kinase",
"definition": "['A protein with core architecture consisting of asignal sequence, 5 Ig-like domains, followed by a transmembrane sequence, followed by a Protein tyrosine kinase domain (Pfam:PF07714). However, only 1-3 of the Ig domains are detected by the Pfam HMMs in most of the sequences. Pfam:PF00047 is most common, but other members of the Ig domain clan, Pfam:PF07679 and Pfam:PF07686 can be identified instead. The fourth Ig domain lacks the disulfide-bonded cysteines.', 'Category=family.']",
"term_type": "cell line"
},
{
"accession": "CLO:0002627",
"name": "CSE-119 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002626",
"name": "CSE 119 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002625",
"name": "CS96 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002624",
"name": "C-S95 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002623",
"name": "C-S91a cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0002622",
"name": "CS87 cell",
"definition": "[]",
"term_type": "cell line"
}
]
}